Agatolimod sodium structure
|
Common Name | Agatolimod sodium | ||
|---|---|---|---|---|
| CAS Number | 541547-35-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Agatolimod sodiumAgatolimod sodium (ODN 7909) is a class B CpG ODN and is a TLR9 agonist. Agatolimod sodium can be used as vaccine adjuvant. Agatolimod sodium can be used for the research of cancer. Sequence: 5’-TCGTCGTTTTGTCGTTTTGTCGTT-3’[1][2]. |
| Name | Agatolimod sodium |
|---|
| Description | Agatolimod sodium (ODN 7909) is a class B CpG ODN and is a TLR9 agonist. Agatolimod sodium can be used as vaccine adjuvant. Agatolimod sodium can be used for the research of cancer. Sequence: 5’-TCGTCGTTTTGTCGTTTTGTCGTT-3’[1][2]. |
|---|---|
| Related Catalog | |
| Target |
TLR9 |
| In Vitro | Agatolimod sodium (ODN 7909) (10 μg/mL; 24 and 48 h) increases radiation sensitivity of radiation-resistant human lung adenocarcinoma cell line by overexpression of TLR9[1]. |
| References |
| No Any Chemical & Physical Properties |